Peter MacBride currently serves as Vice President and Head of Commercial Strategy at Verdiva Bio, a position held since October 2024. Previously, Peter co-founded Aiolos Bio, where responsibilities included overseeing commercial strategy, market planning, and competitive intelligence from May 2022 to April 2024. At Genentech, from November 2013 to May 2022, Peter held roles including Senior Director of Marketing for Alzheimer's Disease, where Peter led the US commercial strategies for gantenerumab, and Director of Pipeline Marketing, focusing on various therapeutic areas. Earlier experience includes consulting at Avalere Health and research roles at PhRMA and the Economy League of Greater Philadelphia. Peter holds a Master of Public Policy in Health Policy from Georgetown University and a Bachelor of Arts in History from the University of Pennsylvania.
This person is not in the org chart
This person is not in any teams
This person is not in any offices